175 related articles for article (PubMed ID: 10758305)
1. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer.
Corvò R; Paoli G; Giaretti W; Sanguineti G; Geido E; Benasso M; Margarino G; Vitale V
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):57-63. PubMed ID: 10758305
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
Corvó R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Orecchia R; Benasso M; Numico GM; Merlano M; Margarino G; Vitale V
Clin Cancer Res; 1997 Nov; 3(11):1993-7. PubMed ID: 9815589
[TBL] [Abstract][Full Text] [Related]
3. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
[TBL] [Abstract][Full Text] [Related]
4. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
5. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck.
Corvò R; Sanguineti G; Vitale V; Bacigalupo A; Margarino G; Benasso M; Numico GM; Giaretti W
Rays; 1997; 22(1 Suppl):69-72. PubMed ID: 9250019
[TBL] [Abstract][Full Text] [Related]
6. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
[TBL] [Abstract][Full Text] [Related]
7. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
[TBL] [Abstract][Full Text] [Related]
8. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
[TBL] [Abstract][Full Text] [Related]
9. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
Dobrowsky W; Dobrowsky E; Wilson GD
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):576-82. PubMed ID: 12573744
[TBL] [Abstract][Full Text] [Related]
10. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
[TBL] [Abstract][Full Text] [Related]
11. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Haustermans K; Fowler JF
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
[TBL] [Abstract][Full Text] [Related]
12. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
13. Cell kinetics analysis in patients affected by squamous cell carcinoma of the head and neck treated with primary surgery and adjuvant radiotherapy.
Corvò R; Margarino G; Sanguineti G; Geido E; Scala M; Mereu P; Cavallari M; Bonanno S; Garaventa G; Barbieri M; Giaretti W
Tumori; 2000; 86(1):53-8. PubMed ID: 10778767
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
Wenz F; Lohr F; Flentje M; Rudat V; Dietz A; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):771-6. PubMed ID: 9128950
[TBL] [Abstract][Full Text] [Related]
16. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
[TBL] [Abstract][Full Text] [Related]
17. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
Alsner J; Høyer M; Sørensen SB; Overgaard J
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome.
Sanguineti G; Corvò R; Sormani MP; Benasso M; Numico G; Bacigalupo A; Rosso R; Vitale V
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):139-47. PubMed ID: 10219807
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy.
Zackrisson B; Gustafsson H; Stenling R; Flygare P; Wilson GD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):677-83. PubMed ID: 9240632
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors.
Struikmans H; Rutgers DH; Hordijk GJ; Slootweg PJ; van der Tweel I; Battermann JJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):27-34. PubMed ID: 9422554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
